NIH Awards $20.4M Task Order for Chronic Disease Research to Social & Scientific Systems

Contract Overview

Contract Amount: $20,391,483 ($20.4M)

Contractor: Social & Scientific Systems, Inc.

Awarding Agency: Department of Health and Human Services

Start Date: 2018-09-25

End Date: 2030-07-22

Contract Duration: 4,318 days

Daily Burn Rate: $4.7K/day

Competition Type: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Pricing Type: COST PLUS FIXED FEE

Sector: R&D

Official Description: TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"

Place of Performance

Location: DURHAM, DURHAM County, NORTH CAROLINA, 27701

State: North Carolina Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $20.4 million to SOCIAL & SCIENTIFIC SYSTEMS, INC. for work described as: TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY" Key points: 1. Significant investment in chronic disease research, a critical public health area. 2. Competition method suggests potential for price discovery, though 'after exclusion of sources' warrants scrutiny. 3. Long duration (12 years) indicates a sustained need for these services. 4. Focus on R&D aligns with NIH's mission, but specific value for money needs further analysis.

Value Assessment

Rating: fair

The contract type is Cost Plus Fixed Fee, which can lead to higher costs if not managed tightly. Benchmarking against similar R&D contracts is difficult without more granular cost data.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded under 'Full and Open Competition After Exclusion of Sources.' While this indicates initial broad competition, the exclusion of sources may limit future price discovery and innovation.

Taxpayer Impact: Taxpayer funds are directed towards critical health research, but the long-term nature and cost-plus structure necessitate careful monitoring to ensure efficiency.

Public Impact

Supports research into chronic diseases, potentially leading to improved public health outcomes. Long-term funding commitment provides stability for research continuity. The research area is vital for understanding and mitigating widespread health issues. Potential for advancements in disease prevention and treatment strategies.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

This contract falls under Research and Development in the Life Sciences. Spending in this sector is driven by innovation and public health needs. Benchmarks are highly variable based on research scope and duration.

Small Business Impact

The awardee, Social & Scientific Systems, Inc., is not listed as a small business. There is no indication of small business subcontracting goals or participation in this specific task order.

Oversight & Accountability

The long duration and cost-plus nature of this contract necessitate robust oversight from NIH to ensure adherence to scope, budget, and research objectives. Regular performance reviews and financial audits are crucial.

Related Government Programs

Risk Flags

Tags

research-and-development-in-the-physical, department-of-health-and-human-services, nc, delivery-order, 10m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $20.4 million to SOCIAL & SCIENTIFIC SYSTEMS, INC.. TASK ORDER 02 AWARD - "CHRONIC DISEASE VALIDATION&ANALYSES IN THE SISTER STUDY"

Who is the contractor on this award?

The obligated recipient is SOCIAL & SCIENTIFIC SYSTEMS, INC..

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (National Institutes of Health).

What is the total obligated amount?

The obligated amount is $20.4 million.

What is the period of performance?

Start: 2018-09-25. End: 2030-07-22.

How effectively will the fixed fee component of this Cost Plus Fixed Fee contract incentivize efficiency and cost control given the 12-year duration?

The effectiveness of the fixed fee in incentivizing efficiency is contingent on the baseline cost estimates and the clarity of the fixed fee's relationship to performance metrics. For a 12-year contract, the initial baseline may become outdated, potentially diminishing the incentive. NIH oversight is critical to ensure the fixed fee remains a meaningful driver of cost control throughout the contract's life.

What are the specific risks associated with excluding sources after initial full and open competition for this long-term R&D task order?

Excluding sources after initial competition may limit future opportunities for competitive bidding on subsequent phases or modifications, potentially leading to higher costs over the contract's 12-year lifespan. It could also stifle innovation if alternative approaches or providers are not considered. This necessitates strong justification for the exclusion and rigorous negotiation of terms.

How will NIH measure the scientific and public health impact of the 'Chronic Disease Validation & Analyses' to ensure the $20.4 million investment yields tangible benefits?

NIH must establish clear, measurable scientific and public health Key Performance Indicators (KPIs) tied to the research objectives. This includes tracking publication rates, data accessibility, development of new analytical tools, and ultimately, contributions to policy or clinical practice guidelines for chronic disease management. Regular scientific reviews and progress reports are essential.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesScientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Product/Service Code: RESEARCH AND DEVELOPMENTOTHER RESEARCH/DEVELOPMENT

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: NIHES201800001

Pricing Type: COST PLUS FIXED FEE (U)

Evaluated Preference: NONE

Contractor Details

Parent Company: DLH Holdings Corp

Address: 8757 GEORGIA AVE STE 1200, SILVER SPRING, MD, 20910

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Small Business, Special Designations, Subchapter S Corporation, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $20,391,483

Exercised Options: $20,391,483

Current Obligation: $20,391,483

Actual Outlays: $9,349,398

Subaward Activity

Number of Subawards: 8

Total Subaward Amount: $1,466,413

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED

Cost or Pricing Data: NO

Parent Contract

Parent Award PIID: 75N96018D00005

IDV Type: IDC

Timeline

Start Date: 2018-09-25

Current End Date: 2030-07-22

Potential End Date: 2030-07-22 00:00:00

Last Modified: 2025-09-23

More Contracts from Social & Scientific Systems, Inc.

View all Social & Scientific Systems, Inc. federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending